Minutes of the JPAC meeting 06-11-2023.pdf (204KB)
Your privacy - how cookies are used by UKBTS UKBTS uses small amounts of data stored on your computer called 'cookies' to collect information about how visitors use the website. You can…
7.7: Components suitable for use in Intrauterine Transfusion, Neonates and Infants under 1 year General requirements Unless they are subjected to a validated pathogen i…
7.6: Granulocyte Components Granulocyte components are manufactured from whole blood-derived buffy coats and are not leucodepleted. Specifications
7.5: Plasma Components Plasma components are manufactured from whole blood or apheresis collections. These components a rapidly frozen to retain labile clotting factors. All plasma compo…
7.4: Platelet Components Platelet components are manufactured from pooling whole blood-derived buffy coats or directly from apheresis collections. They are suspended in plasma with or wi…
7.3: Red Cell Components Red cell components are manufactured from whole blood or apheresis donations and suspended in additive solution and/or plasma. All red cell components are leucoc…
Annexe 3: Provisional Components This section contains information regarding provisional components.
Chapter 21: Tissue banking: tissue retrieval and processing
Chapter 22: Haemopoietic progenitor cells
Chapter 20: Tissue banking: selection of donors
Chapter 19: Tissue banking: general principles
Chapter 18: Platelet immunology
Chapter 17: Granulocyte immunology
Chapter 14: Guidelines for the use of DNA/PCR techniques in Blood Establishments